InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Bolzon Bradley J PhD, Director. Director active across 2 companies, notably CRISPR Therapeutics AG. In total, 5 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €1.3m. Activity tracked since 11 June 2021. The latest transaction was filed on 19 July 2021 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bolzon Bradley J PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
3,504 shares@ US$125.669327.9% of flowCommon SharesSEC:0000899243-21-029271:0
6,515,869 sharesCommon StockSEC:0000899243-21-026769:0
3,216 shares@ US$150.650330.3% of flowCommon SharesSEC:0000899243-21-026800:0
615,607 shares0Common SharesSEC:0000899243-21-026801:0
5,427 shares@ US$125.622541.8% of flowCommon SharesSEC:0000899243-21-023880:0
5 of 5 declarations
About Bolzon Bradley J PhD
Bradley J. Bolzon, PhD, serves as a Director at CRISPR Therapeutics AG and Monte Rosa Therapeutics, Inc. He plays a key role in the governance of these companies and in shaping their strategy. His expertise in biotechnology is an asset to the board.
